Notify me when Lara Sullivan files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PYXS | Pyxis Oncology, Inc. | Common Stock, par value $0.001 per share | 11% | $7,844,727 | +$955,040 | 7,543,007 | +14% | Lara Sullivan, M.D. | 31 Mar 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|